Showing results (71-80 of 108) with videos related to
Sort By:
Pageof 11
Oncology Reports|October 18, 2000
Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancerM Maemura, Y Iino, T Yokoe, et al.Gan No Rinsho. Japan Journal of Cancer Clinics|October 1, 1984
[Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat]Y Iino, K Yamazaki, H Ishikawa, et al.Oncology Reports|May 19, 2011
Combination chemoendocrine therapy containing vindesine for refractory metastatic breast cancerM Maemura, Y Iino, T Yokoe, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|October 26, 2010
Clinical significance of CD133 and hypoxia inducible factor-1α gene expression in rectal cancer after preoperative chemoradiotherapyS Saigusa, K Tanaka, Y Toiyama, et al.Anticancer Research|September 1, 1996
Multidisciplinary treatment with anthracyclines in inflammatory breast cancerY Iino, H Takei, M Maemura, et al.Anticancer Research|July 1, 1995
Subcutaneous mastectomy with axillary dissection plus breast reconstruction using latissimus dorsi myocutaneous flap (or latissimus dorsi muscle) for breast cancerY Iino, H Takei, T Andoh, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
A new triphenylethylene derivative, TAT-59; hormone receptors; insulin-like growth factor 1; and growth suppression of hormone-dependent MCF-7 tumors in athymic miceY Iino, Y Takai, T Ando, et al.Japanese Journal of Cancer Research : Gann|January 1, 1991
The effect of mass screening for breast cancer: results of a multivariate analysisT Kuroishi, S Tominaga, J Ota, et al.Oncology Reports|May 9, 1998
Long-term prognostic value of PCNA labeling index in primary operable breast cancerJ Horiguchi, Y Iino, H Takei, et al.Pageof 11